VAL suppressed TNF-α/IFN-γ-induced TARC/CCL17, MDC/CCL22, CCXCL-8, GM-CSF, and ICAM-1 expressions in HaCaT keratinocytes; thus, it may yield therapeutic efficacy by modulating AD-associated chemokines. The gene discussed is CSF2; the disease is Alzheimer disease.